Journal article · 2023 · Open access
Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit
Trials, 24(1), 400 · Published 13 June 2023 · DOI 10.1186/s13063-023-07284-2
In brief
“Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit” is a 2023 journal article by Rowan Forbes Shepherd and 4 co-authors, published in Trials. OpenAlex counts 11 citations as of 22 November 2026, which puts it in the top 5% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Trials.
- Citations
- 11
- Most cited in
- 2024 (4)
- Field-weighted impact
- 2.01
- References
- 43
- Authors
- 5
Abstract
BACKGROUND: As cancer therapies increase in their complexity, effective communication among patients, physicians, and research staff is critical for optimal clinical trial management. Currently, we understand little about on-trial communication practices and patient trial experiences over time. This mixed-method study explored patient experiences of participating in a clinical drug trial at different time points, focussing on patient communication with trial staff. METHODS: Patients enrolled in clinical drug trials conducted at the Parkville Cancer Clinical Trials Unit were invited to complete a tailored online survey and/or a qualitative interview. Patients were recruited to three cohorts based on time since the first trial treatment: new (≥ 1 to ≤ 13 weeks), mid- (≥ 14 to ≤ 26 weeks), and long-term (≥ 52 weeks) trial patients. Descriptive statistics were calculated for survey responses. Interview data were analysed thematically with a team-based approach. Survey and interview data were integrated at the intepretation stage. RESULTS: From May to June 2021, 210 patients completed a survey (response rate 64%, 60% male), 20 completed interviews (60% male), and 18 completed both. More long-term trial patients (46%) participated than new (29%) and mid-trial patients (26%). Survey data showed high (> 90%) patient satisfaction with the provision of trial information and communication with trial staff across trial stages, and many reported trial experiences as above and beyond standard care. Interview data indicated that written trial information could be overwhelming, and verbal communication with the staff and physicians was highly valued, especially for enrolment and side effect management among long-term patients. Patients described the key points along the clinical trial trajectory that merit close attention: clear and well-communicated randomisation practices, reliable pathways for side effect reporting and prompt response from the trial staff, and end-of-trial transition management to avoid a sense of abandonment. CONCLUSION: Patients reported high overall satisfaction with trial management but outlined key pinch points requiring improved communication practices. Establishing a range of effective communication practices among trial staff and physicians with patients in cancer clinical trials may have a wide range of positive effects on patient accrual, retention, and satisfaction.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Shepherd, R. F., Bradford, A., Lieschke, M., Shackleton, K., & Hyatt, A. (2023). Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit. Trials, 24(1), 400. https://doi.org/10.1186/s13063-023-07284-2
MLA 9
Shepherd, Rowan Forbes, et al. “Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit.” Trials, vol. 24, no. 1, 2023, p. 400. https://doi.org/10.1186/s13063-023-07284-2.
Chicago
Shepherd, Rowan Forbes, Ashleigh Bradford, Marian Lieschke, Kylie Shackleton, and Amelia Hyatt. 2023. “Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit.” Trials 24 (1): 400. https://doi.org/10.1186/s13063-023-07284-2.
Harvard
Shepherd, R. F. et al. (2023) ‘Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit’, Trials, 24(1), p. 400. doi:10.1186/s13063-023-07284-2.
IEEE
R. F. Shepherd, A. Bradford, M. Lieschke, K. Shackleton, and A. Hyatt, “Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit,” Trials, vol. 24, no. 1, p. 400, 2023, doi: 10.1186/s13063-023-07284-2.
BibTeX
@article{shepherd2023patient,
title = {{Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit}},
author = {Shepherd, Rowan Forbes and Bradford, Ashleigh and Lieschke, Marian and Shackleton, Kylie and Hyatt, Amelia},
journal = {Trials},
year = {2023},
volume = {24},
number = {1},
pages = {400},
doi = {10.1186/s13063-023-07284-2},
url = {https://doi.org/10.1186/s13063-023-07284-2}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 4 | |
| 2025 | 3 | |
| 2026 | 4 |
Its field-weighted citation impact is 2.01: it has been cited 2.01 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- cancer clinical trials
- patient communication
- patient experience
- patient satisfaction
- patient retention
- patient accrual
- verbal communication
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Shepherd, R. F., Bradford, A., Lieschke, M., Shackleton, K., & Hyatt, A. (2023). Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit. Trials, 24(1), 400. https://doi.org/10.1186/s13063-023-07284-2
How many times has this paper been cited?
11 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Trials: sign in and open the PDF from this page.
Who wrote this paper?
Rowan Forbes Shepherd, Ashleigh Bradford, Marian Lieschke, Kylie Shackleton, Amelia Hyatt.
What is the DOI of this paper?
10.1186/s13063-023-07284-2, permanently at https://doi.org/10.1186/s13063-023-07284-2. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.